How Can We Help?
Skip to content
Researcher looking at a book

In Vitro ADME & Drug-Drug Interaction Considerations for Toxicologists

  • Published on April 17, 2020
  • ADME 101™
  • Drug Drug Interactions (DDI)
  • Drug Metabolism
  • Webinars

Presenter: Pallavi Limaye, Ph.D., DABT, SEKISUI XenoTech Director of Scientific Consulting with special Q&A guest, Brian Ogilvie, Ph.D., SEKISUI XenoTech Vice President of Scientific Consulting

Originally scheduled to be presented at the canceled Society of Toxicology (SOT) 59th Annual Meeting & ToxExpo, our experts are bringing the tradeshow to you! Dr. Limaye will be discussing the intersection of ADME and toxicology in this webinar, followed by a live Q&A to address audience questions and comments.

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. This ADME 101 webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for such studies that are relevant to interested general toxicologists. Participants will gain insight as to the critical need and utility for in vitro ADME and DDI investigations as related to drug development. Regulatory expectations will be reviewed as will points of particular interest for enabling successful achievement of investigatory goals.

Key concepts discussed in this webinar will include:
  • Why run these studies?
  • Predominant types of in vitro ADME & Drug-Drug Interaction (DDI) studies
  • When to conduct these studies
  • Areas of concern: Proper design & interpretation
  • And other highlights and information…

Request a Copy of the Webinar Slides

What topic would you like to hear about?

Our experts are constantly on the hunt for new and exciting topics to present on, and nothing helps us figure out what you want to hear more than requests and feedback! Use our form to submit your request so we can continue producing educational materials you look forward to

Access ADME